Skip to content
healthcare.dev
Get a free key

REDEMPLO

NDC 84141-025, plozasiran, injection, solution, from Arrowhead Pharmaceuticals, Inc..

Product NDC
84141-025
Status
Listed
Labeler
Arrowhead Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219947
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84141-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PLOZASIRAN25 mg/.5mL

Pharmacologic classes

APOC-III-directed RNA Interaction [EPC]; Increased RNA Degradation [PE]; RNA, Small Interfering [CS]; Small Interfering RNA [EPC]

Package NDCNDC-11Package
84141-025-01841410025011 SYRINGE, GLASS in 1 CARTON (84141-025-01) / 1 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7fd37993-f85a-4af1-8bbe-133299f226ed

Use it

Look up 84141-025 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84141-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84141-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.